Not yet registered on PMX
This profile is generated from public regulatory records. The company has not registered on PMX yet, and PMX has not verified it.
- Country
- Pakistan
- Region
- Asia
Regulatory licences
- DMLName on licence: Citi pharma ltd
Registered products
51 products
*Askprin 150mg TabletAspirin 150mg (USP Specification)150mg*Askprin 75mg TabletAspirin 75mg (USP Specification)75mg*Avazin 10mg TabletCetirizine 2HCl 10mg (USP Specification)10mg*Clopeg 75mg TabletClopidogril Bisulphate equivalent to Clopidogril 75mg(USP Specification)75mgAsknid 200mg TabletsMetronidazole 200mg (USP Specification)200mgAsknid 400mg TabletsMetronidazole 400mg (USP Specification)400mgAskprol 120mg/5ml suspensionParacetamol 120mg (BP Specification) (per 5ml)120mg/5mlAskprol 500mg tabletParacetamol 500mg(B.P. Specification)500mgCefask 200 mg CapsuleCefixime as Trihydrate 200mg (Manufacturer's Specification )200 mgCefask Capsule 400mgCefixime Trihydrate eq. to Cefixime 400mg (Manufacturer Specification)400mgCefask DS 200 mg /5mL SuspensionEach 5mL reconstituted suspension Contains: Cefixime as Trihydrate 200mg (USP Specification )200 mg /5mLCefask Suspension 100mgCefixime Trihydrate eq. to Cefixime 100mg (USP Specification) (per 5ml)100mg/5ml